Skip to main content
. 2015 Dec 5;81(2):362–369. doi: 10.1111/bcp.12798

Figure 2.

Figure 2

Serum and seminal fluid denosumab concentration–time profiles following a single subcutaneo us administration of denosumab 60 mg to healthy male volunteers. Data are means and standard deviations. Inline graphic, Serum (N = 11–12); Inline graphic, Semen (N = 11–12).